Skip to main content
News

News

2 Results
News Artificial Intelligence November 13, 2024
AI is Transforming Life Sciences but Raising Risk Concerns, New Benchmark Report Finds
WASHINGTON, DC, November 13, 2024 — A new report commissioned by Arnold & Porter, based on a survey of 100 senior executives and department heads from biopharmaceutical, digital health, diagnostics, and medical device companies, shows that artificial intelligence (AI) adoption is accelerating across the industry as companies implement it to accelerate product discovery and development, optimize manufacturing and the supply chain, improve marketing and sales strategies, and more.  
» Learn More
News Life Sciences & Healthcare Regulatory November 6, 2023
Philip Desjardins, Former FDA Device Regulator and Johnson & Johnson VP, Rejoins Arnold & Porter’s Life Sciences and Healthcare Regulatory Practice
Washington, D.C., November 6, 2023 — Arnold & Porter announced today that Philip Desjardins, former FDA Center for Devices and Radiological Health Associate Director for Policy and Johnson & Johnson Vice President of Global Regulatory Affairs, has rejoined the firm’s Life Sciences and Healthcare Regulatory practice as a partner, resident in Washington, D.C.
» Learn More